We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Jackson ImmunoResearch Anti-Human IgE Antibodies

Jackson ImmunoResearch Anti-Human IgE Antibodies content piece image
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Jackson ImmunoResearch announces a new addition to its range of products for scientists developing immunoassays for the serology and diagnostics markets.


JIR Mouse Monoclonal Anti-Human IgE antibodies are the latest addition to our suite of products suitable for diagnostics research and development. Specific for Human IgE antibodies, they complement our existing Anti-Human IgG, IgM, and IgA antibodies. Anti-Human IgE is available conjugated to a select range of reporter molecules, including Alkaline Phosphatase and Biotin enabling excellent sensitivity for immunoassay applications.


Jackson ImmunoResearch Anti-Human IgE is a mouse-derived monoclonal antibody with reactivity to human E class immunoglobulins and is epsilon (ε) chain specific and has been tested by ELISA and shows minimal cross-reactivity to other classes of human immunoglobulin (IgG, IgM, or IgA).


JIR Mouse Anti-Human IgE is available conjugated to a range of reporter molecules and is suitable to detect human IgE by a variety of techniques, including ELISA (Enzyme-linked Immunosorbent Assay), Lateral Flow Immunoassay (LFIA), Flow cytometry, Western blot, and CLIA (Chemiluminescent Immunoassay).
Matthew Smith, Commercial Director, commented, "We are excited to launch Jackson ImmunoResearch Anti-Human IgE antibodies as part of our existing suite of reagents suitable for developing high-quality human serology and diagnostic tests. They will allow scientists to harness the sensitivity and specificity of JIR antibodies in a wider range of fields such as allergy."